124 related articles for article (PubMed ID: 23158562)
41. PDN-21 in premenopausal women with systemic lupus erythematosus treated with glucocorticoids.
Navarro MA; Formiga F; Blanco A; Bonnin MR; Nolla JM; Moga I
J Rheumatol; 1995 Dec; 22(12):2238-40. PubMed ID: 8835555
[TBL] [Abstract][Full Text] [Related]
42. Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus.
Kipen Y; Briganti EM; Strauss BJ; Littlejohn GO; Morand EF
Rheumatology (Oxford); 1999 Jan; 38(1):59-65. PubMed ID: 10334684
[TBL] [Abstract][Full Text] [Related]
43. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis.
Teichmann J; Lange U; Stracke H; Federlin K; Bretzel RG
Rheumatol Int; 1999; 18(4):137-40. PubMed ID: 10220833
[TBL] [Abstract][Full Text] [Related]
44. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.
Alsufyani KA; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Nadel H; Malleson PN
J Rheumatol; 2005 Apr; 32(4):729-33. PubMed ID: 15801032
[TBL] [Abstract][Full Text] [Related]
45. Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.
Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Jiménez-Herrera EA; León-Vázquez ML; Montiel-Jarquín Á; García-Carrasco M; Cervera R
PLoS One; 2018; 13(6):e0196113. PubMed ID: 29897913
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.
Bultink IE; Lems WF; Kostense PJ; Dijkmans BA; Voskuyl AE
Arthritis Rheum; 2005 Jul; 52(7):2044-50. PubMed ID: 15986345
[TBL] [Abstract][Full Text] [Related]
47. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.
Formiga F; Moga I; Nolla JM; Pac M; Mitjavila F; Roig-Escofet D
Ann Rheum Dis; 1995 Apr; 54(4):274-6. PubMed ID: 7763104
[TBL] [Abstract][Full Text] [Related]
48. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
Mok CC; To CH; Mak A; Ma KM
Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
[TBL] [Abstract][Full Text] [Related]
49. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus.
Cramarossa G; Urowitz MB; Su J; Gladman D; Touma Z
Lupus; 2017 Apr; 26(4):365-372. PubMed ID: 27522094
[TBL] [Abstract][Full Text] [Related]
51. Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure.
Boone JB; Wheless L; Camai A; Tanner SB; Barnado A
Lupus; 2021 Mar; 30(3):403-411. PubMed ID: 33307984
[TBL] [Abstract][Full Text] [Related]
52. Predictors of decreased bone mineral density in childhood systemic lupus erythematosus: possible role of osteoprotegerin gene polymorphisms.
Eid R; Abdelsalam M; Fathy AA; Abd-El Ghaffar DM; Elmarghany EB; El-Hanafy AA; Mostafa N; Hamdy N; Niazy NA; Hammad A; Abolenein HM
J Pediatr Endocrinol Metab; 2022 Jan; 35(1):79-87. PubMed ID: 34787382
[TBL] [Abstract][Full Text] [Related]
53. Trabecular and cortical bone loss in systemic lupus erythematosus.
Houssiau FA; Lefebvre C; Depresseux G; Lambert M; Devogelaer JP; Nagant de Deuxchaisnes C
Br J Rheumatol; 1996 Mar; 35(3):244-7. PubMed ID: 8620299
[TBL] [Abstract][Full Text] [Related]
54. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.
Rhew EY; Lee C; Eksarko P; Dyer AR; Tily H; Spies S; Pope RM; Ramsey-Goldman R
J Rheumatol; 2008 Feb; 35(2):230-6. PubMed ID: 18203323
[TBL] [Abstract][Full Text] [Related]
55. Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus.
Bhattoa HP; Kiss E; Bettembuk P; Balogh A
Rheumatol Int; 2001 Nov; 21(3):97-102. PubMed ID: 11765229
[TBL] [Abstract][Full Text] [Related]
56. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
[TBL] [Abstract][Full Text] [Related]
57. Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage.
Becker A; Fischer R; Scherbaum WA; Schneider M
Lupus; 2001; 10(11):809-14. PubMed ID: 11789491
[TBL] [Abstract][Full Text] [Related]
58. Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients.
Lim SH; Benseler SM; Tyrrell PN; Charron M; Harvey E; Hebert D; Silverman ED
Ann Rheum Dis; 2011 Nov; 70(11):1991-4. PubMed ID: 21917826
[TBL] [Abstract][Full Text] [Related]
59. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.
Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
Arthritis Rheum; 2004 Nov; 50(11):3591-5. PubMed ID: 15529389
[TBL] [Abstract][Full Text] [Related]
60. Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy.
Coimbra IB; Costallat LT
Joint Bone Spine; 2003 Feb; 70(1):40-5. PubMed ID: 12639616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
